Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Organization During Cognitive Control in ADHD
NCT04349917Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Dec 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of North Carolina at Chapel Hill. Started Dec 2016; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04349917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349917.